Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

Joe O'Sullivan; R.A. Huddart; A.R. Norman; J. Nicholls; D.P. Dearnaley; A. Horwich

doi:10.1093/annonc/mdg020

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

Joe O'Sullivan, R.A. Huddart, A.R. Norman, J. Nicholls, D.P. Dearnaley, A. Horwich

Research output: Contribution to journal › Article › peer-review

257 Citations (Scopus)

Abstract

Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include cumulative bleomycin dose, reduced glomerular filtration rate (GFR), raised creatinine, older age and supplemental oxygen exposure.

Original language	English
Pages (from-to)	91-96
Number of pages	6
Journal	Annals of Oncology
Volume	14
Issue number	1
DOIs	https://doi.org/10.1093/annonc/mdg020
Publication status	Published - 01 Jan 2003

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdg020

Cite this

@article{9980e82eb2e84ea5b20086ce223563c4,

title = "Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours",

abstract = "Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include cumulative bleomycin dose, reduced glomerular filtration rate (GFR), raised creatinine, older age and supplemental oxygen exposure.",

author = "Joe O'Sullivan and R.A. Huddart and A.R. Norman and J. Nicholls and D.P. Dearnaley and A. Horwich",

year = "2003",

month = jan,

day = "1",

doi = "10.1093/annonc/mdg020",

language = "English",

volume = "14",

pages = "91--96",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

AU - O'Sullivan, Joe

AU - Huddart, R.A.

AU - Norman, A.R.

AU - Nicholls, J.

AU - Dearnaley, D.P.

AU - Horwich, A.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include cumulative bleomycin dose, reduced glomerular filtration rate (GFR), raised creatinine, older age and supplemental oxygen exposure.

AB - Background: Bleomycin pulmonary toxicity (BPT) has been known since the early clinical trials of bleomycin in the 1960s. Postulated risk factors include cumulative bleomycin dose, reduced glomerular filtration rate (GFR), raised creatinine, older age and supplemental oxygen exposure.

UR - http://www.scopus.com/inward/record.url?scp=0037250290&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg020

DO - 10.1093/annonc/mdg020

M3 - Article

VL - 14

SP - 91

EP - 96

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 1

ER -

Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this